Guided 5-step workflow with lab tracking, drug-related problem screening, Canadian guideline references, and structured CACP documentation. Built to support pharmacist billing workflows. All outputs require pharmacist review.
Request Access →Comprehensive Annual Care Plans require pharmacists to integrate lab values, medical conditions, current medications, drug-related problems, and clinical guidelines into a cohesive care document. Without structured tools, CACP documentation is time-intensive and prone to gaps that can affect billing claims and audit outcomes. Pharmacists need a system that supports clinical reasoning while ensuring thorough documentation.
RPhNote's Care Plan module walks you through a structured 5-step process that captures clinical information, screens for potential drug-related problems based on patient data, and generates structured documentation with guideline references for pharmacist review.
Enter 9 standard labs (A1C, eGFR, potassium, sodium, LDL, creatinine, ALT, BP) with automatic out-of-range flagging using color-coded indicators.
14 Drug-Related Problem categories with auto-suggestions based on patient age, medications, conditions, and lab values.
Clinical suggestions from Diabetes Canada 2024, Hypertension Canada 2020, CCS Dyslipidemia 2021, GOLD 2024, CANMAT, and Osteoporosis Canada 2023.
First-line therapy references with rationale, contraindication flags, and missing therapy screening for pharmacist consideration.
Structured DATA/ASSESSMENT/PLAN format with DTP assessment, quality checks, and professional PDF export.
Drug Therapy Problem assessment and documentation quality checks structured to support CACP billing workflows.
Demographics, BMI, and basic clinical details.
Active problem list with automatic obesity detection.
Current medication list with clinical metadata.
Drug-related problems with auto-suggestions.
Condition-specific care plans with monitoring.
Complete a comprehensive annual care plan in 15-20 minutes instead of 45+. Guideline lookups and DRP identification are automated.
Guideline-referenced prompts help you consider gaps in therapy, missing monitoring, and optimization opportunities. All suggestions require pharmacist verification.
Every care plan includes structured DTP assessment, quality check section, and numbered references to support your documentation workflow.
Diabetes Canada 2024 CPG, Hypertension Canada 2020, CCS Dyslipidemia 2021, GOLD 2024, CANMAT Guidelines, and Osteoporosis Canada 2023.
Yes. RPhNote supports SMMA-Tobacco and SMMA-Diabetes specialized care plans alongside the standard CACP format.
The system analyzes patient age, medical conditions, current medications, and lab values to auto-suggest potential DRPs from 14 categories. You review and select the clinically relevant ones.